ES2189173T3 - Derivados de 20-aril-5alfa-pregnano. - Google Patents

Derivados de 20-aril-5alfa-pregnano.

Info

Publication number
ES2189173T3
ES2189173T3 ES98924316T ES98924316T ES2189173T3 ES 2189173 T3 ES2189173 T3 ES 2189173T3 ES 98924316 T ES98924316 T ES 98924316T ES 98924316 T ES98924316 T ES 98924316T ES 2189173 T3 ES2189173 T3 ES 2189173T3
Authority
ES
Spain
Prior art keywords
sub
delta
alkyl
alkoxide
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98924316T
Other languages
English (en)
Inventor
Johannes Antonius Joseph Leemhuis
Der Louw Jaap Van
Marinus Bernard Groen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2189173T3 publication Critical patent/ES2189173T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Las invención se refiere a un derivado del 20-aralquil-5a-pregnan que tiene la fórmula general (I), o a una sal farmacológicamente aceptable del mismo, en donde R{sub, 1} es (H, OR), (H, OSO{sub, 3}H) o NOR; R es H, alquilo C{sub,1-6} o acilo C{sub,1-6}; cada R{sub, 2} y R{sub, 3} es independientemente hidrógeno o alquilo C{sub,1-6}; X es un radical hidrocarburo divalente de cadena recta C{sub,1-8}, que comprende opcionalmente un enlace doble o triple; o X es -(CH{sub,2}){sub,m}-CR{sub,7}R{sub,8}-; m = 0-4; al menos una de R{sub,7} y R{sub,8} es alquilo C{sub,1-4} hidróxido, alcóxido C{sub,1-4} o halógeno; el otro, si estuviera presente, es hidrógeno; o R{sub,7} y R{sub,8} representan juntos O o NOR''; R'' es H, alquilo C{sub,1-6} o acilo C{sub,1-6}; cada R{sub,4}, R{sub,5} y R{sub,6} son independientemente hidrógeno, hidróxido, alcóxido C{sub,1-4}, halógeno, NR{sub,9}R{sub,10} o alquilo C{sub,1-4}, opcionalmente sustituido por hidróxido, alcóxido, halógeno u oxo; cada R{sub,9} y R{sub,10} es independientemente hidrógeno o alquilo C{sub,1-4} y las líneas punteadas indican un enlace doble "DELTA" 7 o "DELTA" 8 o bien un par de enlaces dobles conjugados seleccionados entre "DELTA" 7,14, "DELTA" 8,14, "DELTA" 6,8(14). Los compuestos de la invención tienen actividad activadora de la meiosis y pueden utilizarse para el control de la fertilidad.
ES98924316T 1997-05-16 1998-05-11 Derivados de 20-aril-5alfa-pregnano. Expired - Lifetime ES2189173T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201474 1997-05-16

Publications (1)

Publication Number Publication Date
ES2189173T3 true ES2189173T3 (es) 2003-07-01

Family

ID=8228325

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98924316T Expired - Lifetime ES2189173T3 (es) 1997-05-16 1998-05-11 Derivados de 20-aril-5alfa-pregnano.

Country Status (17)

Country Link
US (1) US6177420B1 (es)
EP (1) EP0984980B1 (es)
JP (1) JP2001526673A (es)
KR (1) KR20010012643A (es)
CN (1) CN1260802A (es)
AT (1) ATE229032T1 (es)
AU (1) AU726016B2 (es)
BR (1) BR9808803A (es)
CA (1) CA2289675A1 (es)
DE (1) DE69809905T2 (es)
DK (1) DK0984980T3 (es)
ES (1) ES2189173T3 (es)
HU (1) HUP0002331A3 (es)
NO (1) NO995590L (es)
PL (1) PL337008A1 (es)
TR (1) TR199902793T2 (es)
WO (1) WO1998052965A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1042353B1 (en) * 1997-12-18 2002-07-17 Akzo Nobel N.V. 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives
DE69913513T2 (de) * 1998-05-13 2004-09-30 Novo Nordisk A/S Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
AU4498299A (en) * 1998-06-19 2000-01-10 Novo Nordisk A/S Meiosis regulating compounds
AU2914800A (en) * 1999-03-02 2000-09-21 Akzo Nobel N.V. (androst-5-en-17beta-yl)alkyl sulfoxides and sulfones and their use for control of fertility
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
US6988613B2 (en) * 2001-02-06 2006-01-24 Novo Nordisk A/S Composition for IVF
WO2005020928A2 (en) 2003-08-29 2005-03-10 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
JP2007517878A (ja) 2004-01-15 2007-07-05 ワーナー・チルコット・カンパニー・インコーポレーテッド エチニルエストラジオールのジ−ステロイド型プロドラッグ
JP2007517877A (ja) 2004-01-15 2007-07-05 ワーナー・チルコット・カンパニー・インコーポレーテッド エストラジオールのジ−ステロイド型プロドラッグ
ES2523045T3 (es) 2005-07-12 2014-11-20 Warner Chilcott Company, Llc Derivado éster de etinil estradiol
CA2643732C (en) 2006-02-27 2012-08-21 The Regents Of The University Of California Oxysterol compounds and the hedgehog pathway
CA2707663C (en) 2007-12-03 2017-05-30 The Regents Of The University Of California Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
JP6262723B2 (ja) 2012-05-07 2018-01-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California オキシステロールアナログoxy133は、骨発生及びヘッジホッグシグナル伝達を誘導し、脂肪生成を阻害する
AU2014259672A1 (en) 2013-05-02 2015-12-03 The Regents Of The University Of California Bone-selective osteogenic oxysterol-bone targeting agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
JPH11501806A (ja) 1995-03-06 1999-02-16 ノボ ノルディスク アクティーゼルスカブ 減数分裂の刺激
RU2182909C2 (ru) 1995-06-23 2002-05-27 Ново Нордиск А/С Стероиды, способ регулирования мейоза

Also Published As

Publication number Publication date
ATE229032T1 (de) 2002-12-15
NO995590L (no) 2000-01-11
CA2289675A1 (en) 1998-11-26
EP0984980B1 (en) 2002-12-04
HUP0002331A2 (hu) 2000-12-28
KR20010012643A (ko) 2001-02-26
DE69809905D1 (de) 2003-01-16
PL337008A1 (en) 2000-07-31
NO995590D0 (no) 1999-11-15
DK0984980T3 (da) 2003-03-17
US6177420B1 (en) 2001-01-23
TR199902793T2 (xx) 2000-06-21
AU726016B2 (en) 2000-10-26
HUP0002331A3 (en) 2001-05-28
BR9808803A (pt) 2000-07-18
DE69809905T2 (de) 2003-08-28
EP0984980A1 (en) 2000-03-15
JP2001526673A (ja) 2001-12-18
WO1998052965A1 (en) 1998-11-26
AU7654998A (en) 1998-12-11
CN1260802A (zh) 2000-07-19

Similar Documents

Publication Publication Date Title
ES2189173T3 (es) Derivados de 20-aril-5alfa-pregnano.
ES2106616T3 (es) Derivados de 11,21-bisfenilo-19-nor-pregnanos.
NO2018005I1 (no) tivozanib eller et salt eller solvat derav
ES2126499B1 (es) Coiniciadores de borato para fotopolimerizacion.
UY26754A1 (es) Derivados de la 1, 3, 8, -triaza-spiro (4,5) decan-4-ona
PE20010613A1 (es) Antagonistas de la hormona concentradora de la melanina
ES2112650T3 (es) Sales de un derivado de indol antimigraña.
ES2171577T3 (es) Kappa-opiaceos para enfermedades intestinales inflamatorias.
AR023497A1 (es) Ent-esteroides en calidad de estrogenos con efecto selectivo, su empleo para el tratamiento de las enfermedades y los estados motivados por una deficienciade estrogenos en la mujer y en el hombre, y las composiciones farmaceuticas que contienen estos ent-esteroides
CO5011076A1 (es) Derivados de prolina - d
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
DK0700380T3 (da) N-Alkylthiopolyaminderivater som radioprotektive midler
MX9201805A (es) Derivados de n-imidazolilo de indol substituido, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK0686143T3 (da) Umættede aminoforbindelser som middel mod cancer og mod protozoer
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
DK0399519T3 (da) Potensering af celleformidlet immunitet under anvendelse af polyaminderivater
ATE215555T1 (de) 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose
SE0002211D0 (sv) Methods and compositions for prevention of myopia
UY25708A1 (es) Dihidropironas inhibidoras de hiv proteasa
MX9200178A (es) DERIVADOS DE N-IMIDAZOLILO DE CICLOHEPT (b) INDOL Y TETRAHIDROCARBAZOL SUBSTITUIDOS Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
CO5021190A1 (es) Agentes terapeuticos
CO5150171A1 (es) Derivados de higromicina
DK405589D0 (da) Benzopyrrolidinonderivater fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
ES2096931T3 (es) Derivados de 4-oxa-1-azabiciclo(3,2,0)heptan-7-ona utilizados como agentes antitumorales.
DE69231244D1 (de) Pyrazolothiazolopyrimidin-derivate